Conversion to High Dose Gabapentin Monotherapy in Patients with Medically Refractory Partial Epilepsy

Abstract

GBP monotherapy is well tolerated in daily doses of up to 4,800 mg and is effective in a subgroup of patients with medically refractory partial epilepsy.